Biotech

All Articles

Lykos 'disappointments' certainly not divulging study infractions with author

.Psychopharmacology has actually drawn three articles about midstage clinical test records evaluatin...

Analysts dig into Avidity's DMD gain, revealing distinctions in records

.Avidity Biosciences pleased capitalists with period 1/2 information in Duchenne muscular dystrophy ...

Actinogen's cortisol blocker fails phase 2 clinical depression research study

.Actinogen Medical's cortisol blocker has actually overlooked the main endpoint of a phase 2 researc...

Bivictrix decides going personal only means to take ADC in to center

.Antibody-drug conjugates (ADCs) have actually gone to the center of numerous a billion-dollar biobu...

TPG tops up funds to $580M for expenditures around life sciences

.Asset supervisor TPG, which has actually assisted biotechs like Sionna Therapies as well as Santa A...

Merck quits phase 3 TIGIT test in bronchi cancer cells for futility

.Merck &amp Co.'s TIGIT course has actually suffered an additional misfortune. Months after shutteri...

After a tough year, Exscientia folds up right into Recursion

.After a year defined through pipe hairstyles, the departure of its own chief executive officer and ...

Cullinan, after $25M deal, hands back bispecific to Port

.Cullinan Therapy was actually made an impression on enough along with Harbour BioMed's bispecific i...

A nearer check out Brutal Biotech's Fierce 15

.Within this week's incident of "The Leading Pipe," our company are actually diving into Strong Biot...

Lilly experiences period 2 failure of tau-targeting med

.The confetti is still flying from Eli Lilly's event celebrating the commendation of Alzheimer's hea...